Michael A Stern

US Patent:

6495983, Dec 17, 2002

Filed:

Jun 28, 2001

Appl. No.:

09/892642

Inventors:

Michael A. Stern - San Fernando CA 91340

International Classification:

G05B 1910

US Classification:

318567

Abstract:

An integrated, closed-loop programmable motor assembly ( ) consisting of a bi-directional motor ( ), a motor-shaft encoder ( ), a rotation decoder ( ), a microcontroller ( ) and a motor drive circuit ( ). In a typical application, the electric motor ( ) is first programmed by placing the assembly ( ) in a record mode and then rotating the motor shaft ( ) to describe a desired motion. The motor shaft ( ) can be made to rotate any amount, in any direction, and for any period of time. During the record mode, digital data corresponding to the motor shaft rotation is read from the motor shaft encoder ( ) to the rotation decoder ( ) and is subsequently stored in the memory circuit of the microcontroller ( ). This data is recorded time synchronous, based on the time pulse produced by a time pulse generator ( ). When the assembly ( ) is placed in the playback mode, the stored position data is synchronously read by the microcontroller ( ) via the rotation decoder ( ), and the motor ( ) rotates to reproduce the rotational data manually inserted during the record mode.

US Patent:

D483161, Dec 2, 2003

Filed:

Sep 23, 2002

Appl. No.:

29/167804

Inventors:

Michael Alan Stern - San Fernando CA 91340

International Classification:

1505

US Classification:

D32 25

US Patent:

7135455, Nov 14, 2006

Filed:

Nov 15, 2004

Appl. No.:

10/990054

Inventors:

Michael E. Stern - Mission Viejo CA, US
David Power - Trabuco Canyon CA, US

Assignee:

Allergan, Inc - Irvine CA

International Classification:

A61K 38/12

US Classification:

514 11

Abstract:

Methods of treating humans or animals having various conditions are disclosed which include administering a cyclosporine component. Among the conditions treated are dry mouth syndrome, verruciform xanthoma, achlorhydria, mucous cysts, oral submucous fibrosis, oral nevi, cancer of the oral mucosa, maloplakia of the genito-urinary tract, vulvovaginitis, helicobacter plylori infection, duodenal ulcers, peptic ulcers, conditions affecting the uterus and appendicitis.

US Patent:

7151085, Dec 19, 2006

Filed:

Nov 15, 2004

Appl. No.:

10/990055

Inventors:

Michael E. Stern - Mission Viejo CA, US
David Power - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 38/12

US Classification:

514 11

Abstract:

Methods of treating humans or animals having various conditions are disclosed which include administering a cyclosporinee component. Among the conditions treated are dry mouth syndrome, verruciform xanthoma, achlorhydria, mucous cysts, oral submucous fibrosis, oral nevi, cancer of the oral mucosa, maloplakia of the genito-urinary tract, vulvovaginitis, helicobacter plylori infection, duodenal ulcers, peptic ulcers, conditions affecting the uterus and appendicitis.

US Patent:

7368426, May 6, 2008

Filed:

May 5, 2006

Appl. No.:

11/429050

Inventors:

Michael E. Stern - Mission Viejo CA, US
David Power - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 38/13
A61K 38/12

US Classification:

514 11, 530321

Abstract:

Methods of treating humans or animals having rheumatoid arthritis are disclosed which include topically administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the rheumatoid arthritis.

US Patent:

7902155, Mar 8, 2011

Filed:

Jun 30, 2006

Appl. No.:

11/479741

Inventors:

Michael E. Stern - Mission Viejo CA, US
David Power - Trabuco Canyon CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 38/13

US Classification:

514 205

Abstract:

Methods of treating humans or animals having dysfunctional oral mucosal tissue are disclosed which include topically administering cyclosporine A, salts thereof and/or mixtures thereof in an oral cavity of the human or animal.

US Patent:

8211434, Jul 3, 2012

Filed:

Nov 23, 2009

Appl. No.:

13/129436

Inventors:

Michael E. Stern - Mission Viejo CA, US
Karyn F. Siemasko - Irvine CA, US
Christopher Schaumburg - Irvine CA, US
Jianping Gao - Irvine CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 39/395
C07K 16/40

US Classification:

4241461, 4241331, 4241361, 4241781, 53038826, 5303873, 5303911, 5303891

Abstract:

Disclosed herein is a method of treating dry eye with a KLK-13 antibody.

US Patent:

8491905, Jul 23, 2013

Filed:

Jun 28, 2012

Appl. No.:

13/535994

Inventors:

Michael E. Stern - Mission Viejo CA, US
Karyn F. Siemasko - Irvine CA, US
Christopher Schaumburg - Irvine CA, US
Jianping Gao - Irvine CA, US

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61K 39/395
A61P 27/02
C07K 16/40

US Classification:

4241461, 4241411, 4241311, 4241361, 4241781, 514 208, 53038826, 5303891, 5303881, 5303873, 5303911

Abstract:

Disclosed herein is a method of treating dry eye with a KLK-13 antibody.

Address:

14 Altezza Dr, Mission Viejo, CA 92692

Phone:

9495889419

VIN:

JTHBE5C26C5030744

Make:

LEXUS

Model:

IS 350

Year:

2012